Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Schentag

Showing results (31-40 of 236) with videos related to

Pageof 24
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1977
Renal clearance and tissue accumulation of gentamicinJ J Schentag, W J Jusko
Drug Intelligence & Clinical Pharmacy|November 1, 1987
A clinical pharmacy-oriented drug surveillance network: I. Program descriptionT H Grasela, J J Schentag
Clinical Pharmacokinetics|October 19, 2001
Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein bindingT R Perry, J J Schentag
Lancet (London, England)|February 26, 1977
Gentamicin persistence in the bodyJ J Schentag, W J Jusko
Journal of Pharmaceutical Sciences|February 1, 1984
Noncompartmental determination of the steady-state volume of distribution during multiple dosingI L Smith, J J Schentag
Clinical Chemistry|July 1, 1983
Liquid-chromatographic assay of cefmenoxime in serum and urineD P Reitberg, J J Schentag
Drug Intelligence & Clinical Pharmacy|July 1, 1983
A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic modelJ J Schentag, M H Adelman
Antimicrobial Agents and Chemotherapy|May 1, 1981
Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valvesF M Gengo, J J Schentag
Journal of Clinical Pharmacology|February 1, 1988
The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamicsD E Nix, J J Schentag
Antimicrobial Agents and Chemotherapy|March 1, 1982
Rate of methicillin penetration into normal heart valve and experimental endocarditis lesionsF M Gengo, J J Schentag
Pageof 24

Showing results (31-40 of 236) with videos related to

Sort By:
Pageof 24
Clinical Pharmacology and Therapeutics|September 1, 1977
Renal clearance and tissue accumulation of gentamicinJ J Schentag, W J Jusko
Drug Intelligence & Clinical Pharmacy|November 1, 1987
A clinical pharmacy-oriented drug surveillance network: I. Program descriptionT H Grasela, J J Schentag
Clinical Pharmacokinetics|October 19, 2001
Clinical use of ceftriaxone: a pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein bindingT R Perry, J J Schentag
Lancet (London, England)|February 26, 1977
Gentamicin persistence in the bodyJ J Schentag, W J Jusko
Journal of Pharmaceutical Sciences|February 1, 1984
Noncompartmental determination of the steady-state volume of distribution during multiple dosingI L Smith, J J Schentag
Clinical Chemistry|July 1, 1983
Liquid-chromatographic assay of cefmenoxime in serum and urineD P Reitberg, J J Schentag
Drug Intelligence & Clinical Pharmacy|July 1, 1983
A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic modelJ J Schentag, M H Adelman
Antimicrobial Agents and Chemotherapy|May 1, 1981
Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valvesF M Gengo, J J Schentag
Journal of Clinical Pharmacology|February 1, 1988
The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamicsD E Nix, J J Schentag
Antimicrobial Agents and Chemotherapy|March 1, 1982
Rate of methicillin penetration into normal heart valve and experimental endocarditis lesionsF M Gengo, J J Schentag
Pageof 24